Gastrointestinal cancer: FOLFIRI-improving toxicity in first-line treatment of advanced gastric cancer
- PMID: 25331178
- DOI: 10.1038/nrclinonc.2014.184
Gastrointestinal cancer: FOLFIRI-improving toxicity in first-line treatment of advanced gastric cancer
Comment on
-
Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) study.J Clin Oncol. 2014 Nov 1;32(31):3520-6. doi: 10.1200/JCO.2013.54.1011. Epub 2014 Oct 6. J Clin Oncol. 2014. PMID: 25287828 Clinical Trial.
References
-
- J Clin Oncol. 2014 Nov 1;32(31):3520-6 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical